Vaxcyte, Inc. (PCVX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | -4.99M | 0 | 4.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 4.99M | 0 | -4.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 345.85M | 279.27M | 242.38M | 221.23M | 180.79M | 162.17M | 139.92M | 152.98M | 114.47M | 196.68M | 113.03M | 87.15M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 33.07M | 32.22M | 32.45M | 32.04M | 32.66M | 28.55M | 22.99M | 21.47M | 19.89M | 17.53M | 15.61M | 14.46M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 312.78M | 242.06M | 209.93M | 194.18M | 148.13M | 133.61M | 116.94M | 131.51M | 94.59M | 104.15M | 97.42M | 72.69M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 1000K | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 |
| Operating Income | -345.85M | -274.28M | -242.38M | -226.22M | -180.79M | -162.17M | -139.92M | -152.98M | -114.47M | -196.68M | -113.03M | -87.15M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -91.3% | -69.13% | -73.22% | -47.87% | -57.94% | 17.55% | -23.8% | -75.54% | -60.79% | -127.18% | -92.95% | -81.99% |
| EBITDA | -345.85M | -262.35M | -239.32M | -221.23M | -175.92M | -157.38M | -135.43M | -149.5M | -111.38M | -193.73M | -110.55M | -84.75M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -96.6% | -66.69% | -76.7% | -47.98% | -57.94% | 18.76% | -22.51% | -76.41% | -61.77% | -129.88% | -96.62% | -85.39% |
| D&A (Non-Cash Add-back) | 0 | 11.93M | 3.06M | 4.99M | 4.87M | 4.79M | 4.49M | 3.48M | 3.09M | 2.95M | 2.48M | 2.4M |
| EBIT | 0 | -246.51M | -212.83M | -166.57M | -180.79M | -57.36M | -139.63M | -152.98M | -114.47M | -180.8M | -111.39M | -84.68M |
| Net Interest Income | 0 | 26.45M | 29.26M | 31.07M | 32.94M | 36.46M | 28.06M | 23.81M | 21.67M | 17.57M | 18.5M | 16.45M |
| Interest Income | 26.61M | 26.45M | 29.26M | 31.07M | 32.94M | 36.46M | 28.06M | 23.81M | 21.67M | 17.57M | 18.5M | 16.45M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 25.23M | 27.78M | 29.55M | 59.65M | 40.08M | 25.09M | 36.8M | 24.28M | 19.45M | 15.88M | 20.36M | 18.81M |
| Pretax Income | -320.62M | -246.51M | -212.83M | -166.57M | -140.72M | -137.08M | -103.12M | -128.7M | -95.02M | -180.8M | -92.66M | -68.34M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -320.62M | -246.51M | -212.83M | -166.57M | -140.72M | -137.08M | -103.12M | -128.7M | -95.02M | -180.8M | -92.66M | -68.34M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -127.85% | -79.83% | -106.38% | -29.42% | -48.09% | 24.18% | -11.29% | -88.33% | -57.16% | -131.65% | -59.99% | -40.81% |
| Net Income (Continuing) | -320.62M | -246.51M | -212.83M | -166.57M | -140.72M | -137.08M | -103.12M | -128.7M | -95.02M | -180.8M | -92.66M | -68.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.30 | -1.81 | -1.56 | -1.22 | -1.04 | -1.12 | -0.83 | -1.10 | -0.85 | -1.73 | -0.91 | -0.70 |
| EPS Growth % | -121.15% | -61.61% | -87.95% | -10.91% | -22.35% | 35.26% | 8.79% | -57.14% | -21.43% | -67.96% | 2.15% | 12.5% |
| EPS (Basic) | -2.30 | -1.81 | -1.56 | -1.22 | -1.04 | -1.12 | -0.83 | -1.10 | -0.85 | -1.73 | -0.91 | -0.70 |
| Diluted Shares Outstanding | 139.51M | 136.09M | 136.2M | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 104.42M | 101.67M | 98.06M |
| Basic Shares Outstanding | 139.51M | 136.09M | 136.2M | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 104.42M | 101.67M | 98.06M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |